期刊文献+

韦格纳肉芽肿13例临床分析 被引量:1

在线阅读 下载PDF
导出
摘要 目的总结韦格纳肉芽肿(Wegener s granulomatosis,WG)的临床资料,以提高对本病的早期诊断及治疗水平。方法对13例确诊韦格纳肉芽肿患者的临床资料进行回顾性分析。结果以耳、鼻、喉症状为首发症状6例(46.2%);以肺部症状为首发症状7例(53.8%)。可累积多个系统或脏器,主要累积上、下呼吸道及肾脏。抗中性粒细胞胞质抗体(ANCA)阳性率为84.6%。病理检查是确诊的重要依据,表现为坏死性肉芽肿性炎症、炎细胞浸润的血管炎,阳性率为84.6%。结论了解WG的临床特征,联合抗中性粒细胞胞浆抗体检测及尽可能取得受累部位的病理活检资料,对提高早期的诊断率非常重要,糖皮质激素联合环磷酰胺方案仍是目前WG治疗首选。
出处 《广东医学》 CAS CSCD 北大核心 2010年第6期756-758,共3页 Guangdong Medical Journal
  • 相关文献

参考文献14

  • 1GRENZFORMEN K H.Der Periarteritis nodosa[J].Frankf Z Pathol,1931,42(3):455-480.
  • 2WEGENER F.Uber generalisierte,septische ef(a)berkr(a)nkungen[J].Verh Dtsch Pathol Ges,1936,29(1):202-210.
  • 3WEGENER F.(U)ber eine eigenartige rhinogene Granulomatose mitbesonderer Beteiligung des arterien Systems und der Nieren[J].Beitr Pathol Anat Allg Pathol,1939,41(1):36-68.
  • 4VANDER WOUDE F J,LOBATTO S,PERTAIN H,et al.Autoantibodies against neutmphils and monocytes:tool for diagnosis and marker of disease activity in Wegener's granulomatosis[J].Lancet,1985,1(8426):425-429.
  • 5LEAVITT R Y,FAUCI A S,BITCH D A,et al.The American College of Rheumatology 1990 criteria fm the classification of Wegener's granulomatosis[J].Arthritis Rheum,1990,33(8):1101-1107.
  • 6GENEIK M,BORGNMNN S,ZAHN R,et al.1nmmnogenetic risk factors for an-tineutrcIphil cytoplasmic antibody (ANCA)-associated systemic vascu-litis[J].Clin Exp Immunol,1999,117(2):412-417.
  • 7POPA E R,STEGEMAN C A.KALLENBERG C G,et al.Staplococcus aureus and Wegener's granulomatosis[J].Arthritis Res,2002,4(2):77-79.
  • 8王国春,吴东海.韦格纳肉芽肿病T细胞表达及分泌细胞因子的研究—Th1型免疫反应[J].中华风湿病学杂志,1998,2(2):79-84. 被引量:4
  • 9曾小峰.重视韦格纳肉芽肿病的诊断与治疗[J].中华风湿病学杂志,2003,7(10):587-590. 被引量:16
  • 10LUDEMANN J,CSERNOK E,UIMER M,et al.Antineutrophil cytoplasm antibodies in Wegener is glanttlonlatOSiS;Immunodiagnostic vttllle,monoclonal antibodles and characterization of the target antigen[J].Neth,1990,36(3/4):157-162.

二级参考文献34

  • 1韦格纳肉芽肿病诊治指南(草案)[J].中华风湿病学杂志,2004,8(9):562-564. 被引量:44
  • 2Specks U , Fervenza FC , McDonald TJ , et al . Response of Wegener's granulornatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum, 2001,44: 2836-2840.
  • 3Hensel M, Fiehn C, Ho AD. Stem cell transplantation in primary systemic vasculitis. Med Klin,2003,98:13-18.
  • 4Westman KW,Selga D, Bygren P, et al. Clinical evaluation of acapture EL1SA for detection of proteinase-3 antineutrophil cytolfiasmic antibody. Kidney lnt, 1998,53:1230-1236.
  • 5Rao JY, Wernberg M, Oddone EZ, et al. The role of antineutrophil cytoplasmicantbody (c-ANCA) testing in the diagnosis of Wegener's granulomatosis. Ann Intern Med, 1995,123:425-432.
  • 6Hagen EC, Daha MR, Hermaus J,et al. Diagnostic value of standardized assays for ariti-neutrophil cytophasmic antibodies in idiopathic systemic vaseuiifis EC/BCR project for ANCA assay standardization. Kidney. Int, 1998,53 : 743-753.
  • 7Vassilopoulos D; Niles JL, Vilia-Forte A, et al. Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction. Arthritis Rheum (Arthritis care research) ,2003,49:151-155.
  • 8Komocsi A, Reuter M, Heller M, et al. Active disease and residual damage in treated Wegener's granulomatosis: an observational study using pulmonary high-resolution computed tomography. Eur Radiol, 2003,13: 3642.
  • 9Aasarod K, lversen BM, Hammerstrom J, et al. Wegener' s granulornatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant, 2000,15 : 611-618.
  • 10Koldingsnes W, Nossent JC. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis. J Rheumatol, 2003,30: 80-88.

共引文献21

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部